Main variables	Main activity, secondary one or a tool necessary for production	Total
Companies that carry out R&D in Biotechnology	Total	1.133
Companies that carry out R&D in Biotechnology	Main	564
Companies that carry out R&D in Biotechnology	Secondary dwellings	212
Companies that carry out R&D in Biotechnology	Tool	358
%Companies according to biotechnology used: Genetic code	Total	32
%Companies according to biotechnology used: Genetic code	Main	42
%Companies according to biotechnology used: Genetic code	Secondary dwellings	22
%Companies according to biotechnology used: Genetic code	Tool	20
%Companies according to biotechnology used: Functional units	Total	41
%Companies according to biotechnology used: Functional units	Main	48
%Companies according to biotechnology used: Functional units	Secondary dwellings	40
%Companies according to biotechnology used: Functional units	Tool	30
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Total	27
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Main	33
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Secondary dwellings	24
%Companies according to biotechnology used: Cellular and tissue culturing and engineering	Tool	19
%Companies according to biotechnology used: Bioprocesses	Total	48
%Companies according to biotechnology used: Bioprocesses	Main	41
%Companies according to biotechnology used: Bioprocesses	Secondary dwellings	47
%Companies according to biotechnology used: Bioprocesses	Tool	60
%Companies according to biotechnology used: Sub-cellular organisms	Total	8
%Companies according to biotechnology used: Sub-cellular organisms	Main	11
%Companies according to biotechnology used: Sub-cellular organisms	Secondary dwellings	8
%Companies according to biotechnology used: Sub-cellular organisms	Tool	4
%Companies according to biotechnology used: Bio-computing	Total	21
%Companies according to biotechnology used: Bio-computing	Main	31
%Companies according to biotechnology used: Bio-computing	Secondary dwellings	13
%Companies according to biotechnology used: Bio-computing	Tool	11
%Companies according to biotechnology used: Nanobiotechnology	Total	14
%Companies according to biotechnology used: Nanobiotechnology	Main	18
%Companies according to biotechnology used: Nanobiotechnology	Secondary dwellings	16
%Companies according to biotechnology used: Nanobiotechnology	Tool	7
%Companies according to biotechnology used: Other	Total	13
%Companies according to biotechnology used: Other	Main	13
%Companies according to biotechnology used: Other	Secondary dwellings	15
%Companies according to biotechnology used: Other	Tool	12
%Company by field(s) of ultimate application of biotechnology use: Human Health	Total	50
%Company by field(s) of ultimate application of biotechnology use: Human Health	Main	70
%Company by field(s) of ultimate application of biotechnology use: Human Health	Secondary dwellings	42
%Company by field(s) of ultimate application of biotechnology use: Human Health	Tool	23
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Total	19
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Main	21
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Secondary dwellings	18
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture	Tool	17
%Company by field(s) of ultimate application of biotechnology use: Food products	Total	29
%Company by field(s) of ultimate application of biotechnology use: Food products	Main	22
%Company by field(s) of ultimate application of biotechnology use: Food products	Secondary dwellings	30
%Company by field(s) of ultimate application of biotechnology use: Food products	Tool	40
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Total	21
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Main	19
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Secondary dwellings	25
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production	Tool	23
%Company by field(s) of ultimate application of biotechnology use: Environment	Total	13
%Company by field(s) of ultimate application of biotechnology use: Environment	Main	11
%Company by field(s) of ultimate application of biotechnology use: Environment	Secondary dwellings	20
%Company by field(s) of ultimate application of biotechnology use: Environment	Tool	10
%Company by field(s) of ultimate application of biotechnology use: Industry	Total	13
%Company by field(s) of ultimate application of biotechnology use: Industry	Main	13
%Company by field(s) of ultimate application of biotechnology use: Industry	Secondary dwellings	18
%Company by field(s) of ultimate application of biotechnology use: Industry	Tool	12
Personnel in R&D in biotechnology (no. of persons)	Total	10.706
Personnel in R&D in biotechnology (no. of persons)	Main	5.968
Personnel in R&D in biotechnology (no. of persons)	Secondary dwellings	1.806
Personnel in R&D in biotechnology (no. of persons)	Tool	2.932
Personnel in R&D in biotechnology (no. of persons): Researchers	Total	6.227
Personnel in R&D in biotechnology (no. of persons): Researchers	Main	3.765
Personnel in R&D in biotechnology (no. of persons): Researchers	Secondary dwellings	994
Personnel in R&D in biotechnology (no. of persons): Researchers	Tool	1.467
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Total	4.479
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Main	2.202
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Secondary dwellings	812
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants	Tool	1.464
Personnel in R&D in biotechnology (no. of persons): women	Total	5.795
Personnel in R&D in biotechnology (no. of persons): women	Main	3.402
Personnel in R&D in biotechnology (no. of persons): women	Secondary dwellings	884
Personnel in R&D in biotechnology (no. of persons): women	Tool	1.510
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Total	3.269
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Main	2.049
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Secondary dwellings	503
Personnel in R&D in biotechnology (no. of persons): (women) Researchers	Tool	717
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Total	2.527
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Main	1.353
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Secondary dwellings	381
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants	Tool	793
Personnel in R&D in biotechnology (FTE)	Total	7.716,4
Personnel in R&D in biotechnology (FTE)	Main	4.708,3
Personnel in R&D in biotechnology (FTE)	Secondary dwellings	1.165,8
Personnel in R&D in biotechnology (FTE)	Tool	1.842,3
Personnel in R&D in biotechnology (FTE): Researchers	Total	4.603,1
Personnel in R&D in biotechnology (FTE): Researchers	Main	2.952,5
Personnel in R&D in biotechnology (FTE): Researchers	Secondary dwellings	690,5
Personnel in R&D in biotechnology (FTE): Researchers	Tool	960,1
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Total	3.113,3
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Main	1.755,8
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Secondary dwellings	475,3
Personnel in R&D in biotechnology (FTE): Technicians and assistants	Tool	882,2
Personnel in R&D in biotechnology (FTE): women	Total	4.292,9
Personnel in R&D in biotechnology (FTE): women	Main	2.666
Personnel in R&D in biotechnology (FTE): women	Secondary dwellings	584,9
Personnel in R&D in biotechnology (FTE): women	Tool	1.042
Personnel in R&D in biotechnology (FTE): (women) Researchers	Total	2.446,4
Personnel in R&D in biotechnology (FTE): (women) Researchers	Main	1.592,2
Personnel in R&D in biotechnology (FTE): (women) Researchers	Secondary dwellings	352,1
Personnel in R&D in biotechnology (FTE): (women) Researchers	Tool	502,1
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Total	1.846,5
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Main	1.073,7
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Secondary dwellings	232,8
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants	Tool	539,9
Internal expenditure on R&D (thousands of euros)	Total	616.053
Internal expenditure on R&D (thousands of euros)	Main	401.754
Internal expenditure on R&D (thousands of euros)	Secondary dwellings	86.676
Internal expenditure on R&D (thousands of euros)	Tool	127.622
1) By nature of the expense: Current expenses	Total	574.245
1) By nature of the expense: Current expenses	Main	371.873
1) By nature of the expense: Current expenses	Secondary dwellings	81.601
1) By nature of the expense: Current expenses	Tool	120.772
1.1) Remuneration to researchers	Total	221.741
1.1) Remuneration to researchers	Main	145.148
1.1) Remuneration to researchers	Secondary dwellings	33.906
1.1) Remuneration to researchers	Tool	42.688
1.2) Remuneration to technicians and assistants	Total	102.464
1.2) Remuneration to technicians and assistants	Main	53.306
1.2) Remuneration to technicians and assistants	Secondary dwellings	17.155
1.2) Remuneration to technicians and assistants	Tool	32.002
1.3) Other current expenses	Total	250.041
1.3) Other current expenses	Main	173.419
1.3) Other current expenses	Secondary dwellings	30.540
1.3) Other current expenses	Tool	46.082
2) By nature of the expense: Capital expenses	Total	41.808
2) By nature of the expense: Capital expenses	Main	29.882
2) By nature of the expense: Capital expenses	Secondary dwellings	5.075
2) By nature of the expense: Capital expenses	Tool	6.851
2.1) Land and buildings	Total	5.359
2.1) Land and buildings	Main	3.592
2.1) Land and buildings	Secondary dwellings	486
2.1) Land and buildings	Tool	1.281
2.2) Equipment and instruments	Total	29.489
2.2) Equipment and instruments	Main	20.787
2.2) Equipment and instruments	Secondary dwellings	4.073
2.2) Equipment and instruments	Tool	4.630
2.3) Acquisition of specific R+D software	Total	2.306
2.3) Acquisition of specific R+D software	Main	1.549
2.3) Acquisition of specific R+D software	Secondary dwellings	139
2.3) Acquisition of specific R+D software	Tool	618
2.4) Otros productos de propiedad intelectual específicos para I+D	Total	4.654
2.4) Otros productos de propiedad intelectual específicos para I+D	Main	3.955
2.4) Otros productos de propiedad intelectual específicos para I+D	Secondary dwellings	377
2.4) Otros productos de propiedad intelectual específicos para I+D	Tool	322
1) By origin of the funds: National funds	Total	511.960
1) By origin of the funds: National funds	Main	311.167
1) By origin of the funds: National funds	Secondary dwellings	76.048
1) By origin of the funds: National funds	Tool	124.744
1.1) Own funds	Total	382.335
1.1) Own funds	Main	232.410
1.1) Own funds	Secondary dwellings	47.954
1.1) Own funds	Tool	101.970
1.2) From companies	Total	45.024
1.2) From companies	Main	25.073
1.2) From companies	Secondary dwellings	10.783
1.2) From companies	Tool	9.168
1.3) Public Administration funds	Total	72.387
1.3) Public Administration funds	Main	45.317
1.3) Public Administration funds	Secondary dwellings	16.642
1.3) Public Administration funds	Tool	10.428
1.4) From Universities	Total	363
1.4) From Universities	Main	363
1.4) From Universities	Secondary dwellings	0
1.4) From Universities	Tool	.
1.5) From non profit private institutions	Total	11.851
1.5) From non profit private institutions	Main	8.005
1.5) From non profit private institutions	Secondary dwellings	669
1.5) From non profit private institutions	Tool	3.178
1) By origin of the funds: Foreign funds	Total	104.093
1) By origin of the funds: Foreign funds	Main	90.587
1) By origin of the funds: Foreign funds	Secondary dwellings	10.628
1) By origin of the funds: Foreign funds	Tool	2.879
2.1) From EU programmes	Total	21.825
2.1) From EU programmes	Main	13.669
2.1) From EU programmes	Secondary dwellings	5.814
2.1) From EU programmes	Tool	2.342
2.2) Other foreign funds	Total	82.269
2.2) Other foreign funds	Main	76.918
2.2) Other foreign funds	Secondary dwellings	4.813
2.2) Other foreign funds	Tool	537
Purchase of R&D services in biotechnology (thousands of euros)	Total	144.342
Purchase of R&D services in biotechnology (thousands of euros)	Main	91.533
Purchase of R&D services in biotechnology (thousands of euros)	Secondary dwellings	26.448
Purchase of R&D services in biotechnology (thousands of euros)	Tool	26.360
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Total	70.458
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Main	43.549
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Secondary dwellings	11.885
Purchase of R&D services in biotechnology (thousands of euros): In Spain	Tool	15.023
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Total	73.885
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Main	47.984
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Secondary dwellings	14.563
Purchase of R&D services in biotechnology (thousands of euros): Abroad	Tool	11.337
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Total	48
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Main	57
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Secondary dwellings	46
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital	Tool	35
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Total	13
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Main	12
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Secondary dwellings	14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information	Tool	14
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Total	15
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Main	15
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Secondary dwellings	16
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources	Tool	14
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Total	12
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Main	12
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Secondary dwellings	18
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain	Tool	11
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Total	16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Main	18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Secondary dwellings	21
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets	Tool	9
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Total	16
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Main	20
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Secondary dwellings	18
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels	Tool	9
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Total	16
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Main	17
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Secondary dwellings	18
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception	Tool	11
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Total	36
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Main	40
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Secondary dwellings	43
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements	Tool	26
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Total	49
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Main	56
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Secondary dwellings	47
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost	Tool	39
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Total	18
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Main	17
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Secondary dwellings	24
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting	Tool	16
% Companies that have requested biotechnology patents	Total	16
% Companies that have requested biotechnology patents	Main	24
% Companies that have requested biotechnology patents	Secondary dwellings	8
% Companies that have requested biotechnology patents	Tool	7
Number of patents requested	Total	633
Number of patents requested	Main	474
Number of patents requested	Secondary dwellings	71
Number of patents requested	Tool	88
% Companies with income of an international origin related to biotechnological activities	Total	24
% Companies with income of an international origin related to biotechnological activities	Main	32,7
% Companies with income of an international origin related to biotechnological activities	Secondary dwellings	15,5
% Companies with income of an international origin related to biotechnological activities	Tool	15,2
% Turnover representing income of an international origin related to biotechnological activities	Total	1,4
% Turnover representing income of an international origin related to biotechnological activities	Main	9
% Turnover representing income of an international origin related to biotechnological activities	Secondary dwellings	0,1
% Turnover representing income of an international origin related to biotechnological activities	Tool	2,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Total	57,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Main	35,5
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Secondary dwellings	37,3
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU	Tool	77,6
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Total	42,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Main	64,5
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Secondary dwellings	62,7
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries	Tool	22,4
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Total	82,3
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Main	91,3
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Secondary dwellings	80,2
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services	Tool	74,3
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Total	16,5
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Main	7,1
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Secondary dwellings	.
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain	Tool	25,6
% Income of an international origin related with activities according to the classification: Operating source abroad	Total	1
% Income of an international origin related with activities according to the classification: Operating source abroad	Main	1,1
% Income of an international origin related with activities according to the classification: Operating source abroad	Secondary dwellings	19,6
% Income of an international origin related with activities according to the classification: Operating source abroad	Tool	0,1
% Income of an international origin related with activities according to the classification: Other	Total	0,3
% Income of an international origin related with activities according to the classification: Other	Main	0,6
% Income of an international origin related with activities according to the classification: Other	Secondary dwellings	0,2
% Income of an international origin related with activities according to the classification: Other	Tool	0